These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22430957)

  • 1. Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model.
    Labrou M; Michail G; Ntokou E; Pittaras TE; Pournaras S; Tsakris A
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3388-91. PubMed ID: 22430957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.
    Ikonomidis A; Michail G; Vasdeki A; Labrou M; Karavasilis V; Stathopoulos C; Maniatis AN; Pournaras S
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3905-8. PubMed ID: 18694946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
    Khorvash F; Mostafavizadeh K; Mobasherizadeh S
    Pak J Biol Sci; 2008 May; 11(9):1282-5. PubMed ID: 18819540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
    Sakoulas G; Gold HS; Venkataraman L; DeGirolami PC; Eliopoulos GM; Qian Q
    J Clin Microbiol; 2001 Nov; 39(11):3946-51. PubMed ID: 11682512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of clinical isolates of oxacillin-susceptible mecA-positive Staphylococcus aureus in China from 2009 to 2014.
    Song Y; Cui L; Lv Y; Li Y; Xue F
    J Glob Antimicrob Resist; 2017 Dec; 11():1-3. PubMed ID: 28729204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
    Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
    Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
    Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F
    Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
    Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
    Park YS; Shin WS; Kim SK
    J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal diversity and epidemiological characteristics of Staphylococcus aureus: high prevalence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with clinical isolates in Brazil.
    Andrade-Figueiredo M; Leal-Balbino TC
    BMC Microbiol; 2016 Jun; 16(1):115. PubMed ID: 27325108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
    Nodzo SR; Boyle KK; Frisch NB
    J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of Methicillin-Resistant Staphylococcus aureus (MRSA) and Borderline Oxacillin Resistant Staphylococcus aureus (BORSA) in community and food of animal origin.
    Zehra A; Gulzar M; Singh R; Kaur S; Gill JPS
    FEMS Microbiol Lett; 2020 Dec; 367(23):. PubMed ID: 33278300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
    Joukhadar C; Pillai S; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2010 Feb; 54(2):773-7. PubMed ID: 19933805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams.
    Gostev V; Sabinova K; Sopova J; Kalinogorskaya O; Sulian O; Chulkova P; Velizhanina M; Pavlova P; Danilov L; Kraeva L; Polev D; Martens E; Sidorenko S
    Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1125-1133. PubMed ID: 37515660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.
    Hertlein T; Sturm V; Lorenz U; Sumathy K; Jakob P; Ohlsen K
    Antimicrob Agents Chemother; 2014; 58(3):1630-8. PubMed ID: 24366730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy.
    Moyenuddin M; Ohl CA; Williamson JC; Peacock JE
    J Antimicrob Chemother; 2003 Jan; 51(1):202-3. PubMed ID: 12493820
    [No Abstract]   [Full Text] [Related]  

  • 18. High Proportion of Oxacillin-Susceptible
    Megantara I; Lesmana R; Sylviana N; Cahyadi AI; Sudigdoadi S
    Pak J Biol Sci; 2021 Jan; 24(6):680-687. PubMed ID: 34486344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to dicloxacillin, methicillin and oxacillin in methicillin-susceptible and methicillin-resistant Staphylococcus aureus detected by dilution and diffusion methods.
    Rosdahl VT; Frimodt-Møller N; Bentzon MW
    APMIS; 1989 Aug; 97(8):715-22. PubMed ID: 2669854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA.
    Hernandez BN; Dilworth T; Kesner J; Ryan K; Thelen H; Mercier RC
    Chemotherapy; 2023; 68(1):55-60. PubMed ID: 36001946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.